SEOUL, Nov. 1 (Yonhap) -- Hanmi Pharm Co. on Tuesday reported its third-quarter net profit of 31.3 billion won (US$22.1 million), up 11.5 percent from a year earlier.
The company said in a regulatory filing that it posted 46.8 billion won in operating profit for the quarter, compared with 36.9 billion won a year ago. Sales rose 12.9 percent to 342.1 billion won.
The earnings beat market expectations. The average estimate of net profit by analysts stood at 23.2 billion won, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.
S. Korea submits proposal to Turkey on new nuclear power project
U.S., S. Korea agree to expand joint military drills, take strong steps against N. Korean provocations
S. Korea to test-launch new 'high-power' Hyunmoo ballistic missile this week: source
China imposes mandatory virus tests for arrivals from S. Korea only in latest protest over curbs
Yoon, first lady meet Cambodian child at presidential office